Related Experiment Video
Updated: Jul 13, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
ANXA7 expression represents hormone-relevant tumor suppression in different cancers
Meera Srivastava1, Yelizaveta Torosyan, Mark Raffeld
1Department of Anatomy, Physiology and Genetics, and Institute for Molecular Medicine, Uniformed Services University School of Medicine (USUHS), Bethesda, MD, USA. msrivastava@usuhs.mil
Abstract:
Tumor suppressor function of ubiquitously expressed Annexin-A7, ANXA7 (10q21) that is involved in exocytosis and membrane fusion was based on cancer prone phenotype in Anxa7(+/-) mice as well as ANXA7 role in human prostate and breast cancers. To clarify ANXA7 biomarker and tumor suppressor function, we analyzed its expression pattern in comparison to the prostate-specific biomarker NKX3.1. Immunohistochemistry-based ANXA7 and NKX3.1 protein expression was analyzed on human tissue microarrays of 4,061 specimens from a wide spectrum of the histopathologically well-characterized tumors in different stages compared to corresponding normal tissues. Decreased ANXA7 expression was mostly associated with high invasive potential in multiple tumors. Although some metastases retained relatively high ANXA7 rates compared to primary cancer tissues, the lymph node metastases from different sites (including prostate and breast) had decreased ANXA7 expression in comparison to the intact lymphatic tissues. Major ANXA7 downregulation pattern was deviated in tumors of glandular (especially neuroendocrine) origin. ANXA7 and NKX3.1 proteins were synexpressed in the male urogenital system and adrenal gland. Gene expression profiling in prostate and breast cancers (SMD) revealed distinct hormone-related profiles for NKX3.1 and ANXA7, where ANXA7 expression correlated with steroid sulfatase which has a pivotal role in steroidogenesis. Abundant protein presence in adrenal gland and its loss in hormone-refractory prostate cancer indicated that ANXA7 can be relevant to steroidogenesis and androgen sensitivity in particular. With tumor suppressor pattern validated in different tumors, ANXA7 can be an attractive diagnostic and therapeutic target associated with the hormone and/or neurotransmitter-mediated modulation of tumorigenesis.
Insights
Annexin-A7 (ANXA7) acts as a tumor suppressor, with decreased expression linked to invasive cancers. Its role in steroidogenesis suggests potential as a diagnostic and therapeutic target for hormone-related tumorigenesis.
Area of Science:
- Molecular oncology and biomarker discovery
- Cancer biology and tumor suppression mechanisms
Background:
- Annexin-A7 (ANXA7) is a ubiquitously expressed protein involved in exocytosis and membrane fusion.
- Previous studies suggested ANXA7's tumor suppressor role based on mouse models and its involvement in prostate and breast cancers.
Purpose of the Study:
- To clarify the biomarker and tumor suppressor functions of ANXA7.
- To analyze ANXA7 expression patterns in various human tumors compared to normal tissues and the prostate-specific biomarker NKX3.1.
Main Methods:
- Immunohistochemistry was used to analyze ANXA7 and NKX3.1 protein expression.
- Human tissue microarrays of 4,061 specimens covering diverse tumors and normal tissues were examined.
- Gene expression profiling data from prostate and breast cancers (SMD) were analyzed.
Main Results:
- Decreased ANXA7 expression correlated with high invasive potential across multiple tumor types.
- Lymph node metastases showed reduced ANXA7 expression compared to intact lymphatic tissues.
- ANXA7 downregulation was notable in glandular tumors, particularly neuroendocrine types, and linked to steroidogenesis and androgen sensitivity.
Conclusions:
- ANXA7 exhibits a validated tumor suppressor pattern across various cancers.
- ANXA7's association with steroidogenesis and hormone sensitivity positions it as a potential diagnostic and therapeutic target.
- Further research into ANXA7's role in modulating tumorigenesis via hormone and neurotransmitter pathways is warranted.
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...